Logo

FDA Clears Roche's PCR Test for Detecting West Nile Virus in Donor Blood

Aug 29, 2007
NEW YORK (GenomeWeb News) — Roche Diagnostics today said that the US Food and Drug Administration has cleared its PCR-based test for detecting West Nile Virus in donated human blood and plasma.
 
The test, called the cobas TaqScreen West Nile Virus test, enables researchers to detect the virus earlier in the infection cycle in donors who may show no symptoms of disease, according to Roche.
 
Though the virus is principally transmitted to humans through mosquito bites, it can also infect humans by transfusion of infected blood or blood products.
 
According to the US Center for Disease Control and Prevention, US-based blood-screening centers identified 340 donors whose blood tested positive for West Nile virus in 2006 and 23 so far in 2007.

Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.